The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo
Abstract Glucagon like peptide-1 (GLP-1) plays a vital role in glucose homeostasis and sustaining β-cell function. Currently there are two major methods to enhance endogenous GLP-1 activity; inhibiting dipeptidyl peptidase-4 (DPP4) or activating G protein-coupled receptor 119 (GPR119). Here we descr...
Saved in:
Main Authors: | Yi Huan, Qian Jiang, Gang Li, Guoliang Bai, Tian Zhou, Shuainan Liu, Caina Li, Quan Liu, Sujuan Sun, Miaomiao Yang, Nan Guo, Xing Wang, Shusen Wang, Yaojuan Liu, Guanqiao Wang, Haihong Huang, Zhufang Shen |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/b7cf3b9f7d1d47d2a96769334b00ea7b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel GPR119 agonist DA-1241 preserves pancreatic function via the suppression of ER stress and increased PDX1 expression
by: Mi-Kyung Kim, Ph.D, et al.
Published: (2021) -
Acta No. 119
by: Banco Central de Chile
Published: (2019) -
Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes
by: Guoxia Ji, et al.
Published: (2021) -
Revista CEPAL no. 119
Published: (2016) -
CEPAL Review no. 119
Published: (2016)